MA32211B1 - Traitement de troubles oculaires - Google Patents

Traitement de troubles oculaires

Info

Publication number
MA32211B1
MA32211B1 MA33226A MA33226A MA32211B1 MA 32211 B1 MA32211 B1 MA 32211B1 MA 33226 A MA33226 A MA 33226A MA 33226 A MA33226 A MA 33226A MA 32211 B1 MA32211 B1 MA 32211B1
Authority
MA
Morocco
Prior art keywords
treatment
eye disorders
diabetic
emphysema
thanks
Prior art date
Application number
MA33226A
Other languages
Arabic (ar)
English (en)
Inventor
Thomas Oligino
Chang Hahn
Timothy A Gillespy
Ramalinga Dharanipragada
Ellen Matzkin
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of MA32211B1 publication Critical patent/MA32211B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention porte sur un traitement pour des troubles oculaires, tels que la dégénérescence maculaire, et de préférence la dégénérescence maculaire liée à l'âge, la rétinopathie diabétique et l'sdème maculaire diabétique, à l'aide d'un composé de formule i.
MA33226A 2008-03-10 2010-10-06 Traitement de troubles oculaires MA32211B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3507308P 2008-03-10 2008-03-10
PCT/US2009/036119 WO2009114373A1 (fr) 2008-03-10 2009-03-05 Traitement pour des troubles oculaires

Publications (1)

Publication Number Publication Date
MA32211B1 true MA32211B1 (fr) 2011-04-01

Family

ID=40583469

Family Applications (1)

Application Number Title Priority Date Filing Date
MA33226A MA32211B1 (fr) 2008-03-10 2010-10-06 Traitement de troubles oculaires

Country Status (22)

Country Link
EP (1) EP2285378A1 (fr)
JP (1) JP2011513488A (fr)
KR (1) KR20110009084A (fr)
CN (1) CN101965188A (fr)
AR (1) AR070975A1 (fr)
AU (1) AU2009223501A1 (fr)
BR (1) BRPI0909659A2 (fr)
CA (1) CA2717991A1 (fr)
CL (1) CL2009000551A1 (fr)
CO (1) CO6290691A2 (fr)
CR (1) CR11644A (fr)
DO (1) DOP2010000266A (fr)
IL (1) IL207906A0 (fr)
MA (1) MA32211B1 (fr)
MX (1) MX2010008308A (fr)
NI (1) NI201000131A (fr)
NZ (1) NZ587906A (fr)
RU (1) RU2010141560A (fr)
SV (1) SV2010003658A (fr)
TW (1) TW200950784A (fr)
WO (1) WO2009114373A1 (fr)
ZA (1) ZA201005337B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR074776A1 (es) 2008-12-18 2011-02-09 Sanofi Aventis Metodo para tratar la degeneracion macular; modulando el sistema inmunitario del paciente
EP2441755A1 (fr) 2010-09-30 2012-04-18 Almirall, S.A. Dérivés de pyridine et isoquinoline comme inhibiteurs des kinases Syk et JAK
EP2489663A1 (fr) 2011-02-16 2012-08-22 Almirall, S.A. Composés en tant qu'inhibiteurs de la syk kinase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001047922A2 (fr) * 1999-12-24 2001-07-05 Aventis Pharma Limited Azaindoles
EP1259236A4 (fr) * 2000-02-25 2004-11-03 Merck & Co Inc Inhibiteurs de tyrosine-kinase
KR101487027B1 (ko) * 2005-09-30 2015-01-28 미카나 테라퓨틱스, 인크. 치환된 피라졸 화합물
CL2007002617A1 (es) * 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.

Also Published As

Publication number Publication date
SV2010003658A (es) 2011-01-31
RU2010141560A (ru) 2012-04-20
NZ587906A (en) 2011-12-22
MX2010008308A (es) 2010-08-11
TW200950784A (en) 2009-12-16
AR070975A1 (es) 2010-05-19
CA2717991A1 (fr) 2009-09-17
CL2009000551A1 (es) 2009-08-21
DOP2010000266A (es) 2010-09-30
CO6290691A2 (es) 2011-06-20
CN101965188A (zh) 2011-02-02
ZA201005337B (en) 2011-04-28
JP2011513488A (ja) 2011-04-28
EP2285378A1 (fr) 2011-02-23
IL207906A0 (en) 2010-12-30
WO2009114373A1 (fr) 2009-09-17
BRPI0909659A2 (pt) 2015-09-22
NI201000131A (es) 2011-09-29
CR11644A (es) 2010-11-22
AU2009223501A1 (en) 2009-09-17
KR20110009084A (ko) 2011-01-27

Similar Documents

Publication Publication Date Title
GEP20146072B (en) New compounds
EA201001647A1 (ru) Производные бензофурана, бензотиофена, бензотиазола в качестве fxr модуляторов
MA37571A1 (fr) Compositions pesticides et procédés correspondants
EA201590053A1 (ru) Модуляторы пути системы комплемента и их применение
MY170713A (en) Treatment protocol of diabetes type 2
MX2015007916A (es) Peri-carbinoles.
UA113051C2 (xx) Гетероциклічні похідні та їх застосування у лікуванні неврологічних розладів
EA201001639A1 (ru) Композиции и способы их получения и применения
MA35920B1 (fr) Composés destinés au traitement de l'amyotrophie spinale
CU24083B1 (es) Derivados de oxazina útiles como inhibidores de bace para el tratamiento de trastornos neurológicos
EA201200176A1 (ru) Производные оксазина и их применение для лечения неврологических нарушений
ECSP066373A (es) Forma cristalina beta de clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmacéuticas que la contienen
SG178963A1 (en) Compounds as tyrosine kinase modulators
MY160468A (en) Novel amino azaheterocyclic carboxamides
AU2012321815A8 (en) 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
BR112014008759A8 (pt) Tratamento de doença ocular
PH12014502624B1 (en) Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
CR20130264A (es) Compuestos pirimidinona para uso en el tratamiento de enfermedades o condiciones mediadas por lp-pla2
MA32505B1 (fr) 5-alcynyl-pyrimidines
EA201500182A1 (ru) 4-МЕТИЛ-2,3,5,9,9b-ПЕНТААЗАЦИКЛОПЕНТА[a]НАФТАЛИНЫ
UA108878C2 (ru) Ингибиторы протеинтирозинкиназной активности
GEP20156315B (en) Oxazoline and isoxazoline derivatives as crac modulators
BRPI0720050A2 (pt) 6-oxo-1,6-diidropirimidin-2-ilas no tratamento de doenças proliferativas
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
BRPI0918580B8 (pt) polimorfo cristalino b da n-(2-aminofenil)-4-[n-(piridina3-il)metóxi-carbonilaminometil]-benzamida, composição e combinação contendo o mesmo, uso e seu processo de produção